The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis

Seizure

Volumn 12, Issue 5, 2003, Pages 316-318

  Favale, E ^a   Audenino, D ^a   Cocito, L ^a   Albano, Claudio ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

5 HTP; Allopregnanolone; Epileptogenesis

Indexed keywords

BARBEXACLONE; CARBAMAZEPINE; CITALOPRAM; PHENOBARBITAL; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; VALPROIC ACID;

ADD ON THERAPY; ADULT; ANTICONVULSANT ACTIVITY; ARTICLE; AUTONOMIC NEUROPATHY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE CONTROL; DOSE RESPONSE; DROWSINESS; DRUG BLOOD LEVEL; DRUG EFFECT; EPILEPSY; EPILEPTOGENESIS; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; TREATMENT OUTCOME;

EID: 0038083311     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1059-1311(02)00315-1     Document Type: Article

References (13)

1. Scudder, C. L., Karczmar, A. G., Everett, G. M., Gibson, J. E. and Rifkin, M. Brain catecholamines and serotonin levels in various strains and genera of mice and a possible interpretation for the correlation of amine levels with electroshock latency and behaviour. International Journal of Neuropharmacology 1966; 5: 343-351.
2. Lunardi, G., Mainardi, P., Rubino, V. et al. Tryptophan and epilepsy. In: Recent Advances in Tryptophan Research (Eds G. Allegri Filippini and V. L. Costa). New York and London, Plenum Press, 1995: pp. 101-102.
3. Pasini, A., Tortorella, A. and Gale, K. Anticonvulsant effect of intranigral fluoxetine. Brain Research 1992; 593: 287-290.
4. Favale, E., Rubino, V., Mainardi, P., Lunardi, G. and Albano, C. Anticonvulsant effect of fluoxetine in humans. Neurology 1995; 45: 1926-1927.
5. Garcia-Colunga, J., Awad, J. N. and Miledi, R. Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac). Proceedings of the National Academy of Sciences of the United States of America 1997; 94: 2041-2044.
6. Uzunov, D. P., Cooper, T. B., Costa, E. and Guidotti, A. Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proceedings of the National Academy of Sciences of the United States of America 1996; 93: 12599-12604.
7. Hyttel, J. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). International Clinical Psychopharmacology 1994; 9 (Suppl. 1): 19-26.
8. Lambert, M. V. and Robertson, M. M. Depression in epilepsy: etiology, phenomenology, and treatment. Epilepsia 1999; 40 (Suppl. 10): S21-S47.
9. Rosenstein, D. L., Nelson, J. C. and Jacobs, S. C. Seizures associated with antidepressants: a review. Journal of Clinical Psychiatry 1993; 54: 289-299.
10. Lanes, T. and Ravaris, C. L. Prolonged ECT seizure duration in a patient taking trazodone [letter]. American Journal of Psychiatry 1993; 150: 525.
11. Kaufman, K. R. and Kaufman, E. R. Psychotropic management of seizure duration during electroconvulsive therapy: trazodone, a case report. Irish Journal of Psychological Medicine 1992; 9: 50-51.
12. Pesola, G. R. and Avasarala, J. Bupropion seizure proportion among new-onset generalized seizures and drug related seizures presenting to an emergency department. Journal of Emergency Medicine 2002; 22: 235-239.
13. Bradford, H. F. Glutamate, GABA and epilepsy. Progress in Neurobiology 1995; 47: 477-511.